Supernus Pharmaceuticals, Inc. (SUPN)

51.80 +0.09 (+0.17%) USD  |  NASDAQ  |  Dec 24, 12:59
51.77 -0.03 (-0.06%) After-Hours: 13:59
More

Supernus Pharmaceuticals CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
BridgeBio Pharma, Inc. Upgrade
The Cooper Cos., Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --